Epidemiological studies have related a diet rich in fruits and vegetables to the prevention of chronic degenerative diseases linked to oxidative stress(Reference Ramos1). Thus, the antioxidant activity of polyphenols has widely been involved in the explanation of their protective properties(Reference Azam, Hadi and Khan2, Reference Chen, Yang and Jiao3). Additionally, these protective effects have been demonstrated to be mediated by mechanisms not only related to their antioxidant activity(Reference Granado-Serrano, Martín and Izquierdo-Pulido4, Reference Granado-Serrano, Martín and Goya5).
Epicatechin is a flavonoid commonly found in the diet, particularly abundant in cocoa(Reference D'Archivio, Filesi and Di Benedetto6, Reference Manach, Scalbert and Morand7). Numerous studies have demonstrated that epicatechin possesses in vitro antioxidant activity, can effectively scavenge free radicals(Reference Azam, Hadi and Khan2, Reference Chen, Yang and Jiao3) and may play a role in modulating oxidative stress by preventing reactive oxygen species (ROS) generation(Reference Granado-Serrano, Martín and Izquierdo-Pulido4, Reference Granado-Serrano, Martín and Goya5, Reference Kim, Kang and Pyun8). Moreover, epicatechin exerts a cytoprotective role since it activates survival and proliferation pathways(Reference Granado-Serrano, Martín and Izquierdo-Pulido4, Reference Granado-Serrano, Martín and Goya5). In this regard, it has been suggested that epicatechin might exert beneficial actions by stimulating the antioxidant defence response through the redox-regulated transcription factors and by modulating gene expression and signal cascades, such as mitogen-activated protein kinases (MAPK)(Reference Granado-Serrano, Martín and Izquierdo-Pulido4, Reference Noé, Peñuelas and Lamuela-Raventós9, Reference Williams, Spencer and Rice-Evans10). However, further studies to elucidate its molecular mechanism of action are needed.
A number of transcription factors have been connected to the oxidative stress, such as NF-κB, activator protein-1 (AP-1) and nuclear factor erythroid 2p45-related factor-2 (Nrf2), which also modulate signalling pathways involved in the regulation of cell detoxification, proliferation, survival, death and differentiation(Reference Gopalakrishnan and Tony Kong11, Reference Shaulian and Karin12). NF-κB is activated in the cytoplasm by disruption of the association of NF-κB with inhibitor of κB protein (IκB). The phosphorylation of IκB by the IκB kinase (IKK) complex results in the degradation of IκB, leading to the nuclear translocation of NF-κB where it can transactivate NF-κB target genes involved in cell proliferation, anti-apoptosis, survival, etc(Reference Naugler and Karin13).
AP-1 is a transcription factor associated with cell proliferation, survival, differentiation, apoptosis and stress responses(Reference Shaulian and Karin12, Reference Czaja14, Reference Hess, Angel and Schorpp-Kistner15). AP-1 is a dimer most commonly formed by the combination of structurally and functionally related members of the Jun protein family (c-Jun, JunB and JunD) and the Fos protein family (c-Fos, FosB, Fra-1 and Fra-2)(Reference Shaulian and Karin12, Reference Hess, Angel and Schorpp-Kistner15, Reference Kwon, Barve and Yu16). AP-1 induction is modulated by different mechanisms, one of which is mediated by the MAPK cascade, such as c-jun amino-terminal kinase(Reference Czaja14). Once activated, c-jun amino-terminal kinase phosphorylates and activates c-Jun, which enhances the AP-1 transcriptional activity.
Nrf2 plays a central role in the induction of phase II detoxifying enzymes through its binding to the antioxidant response element. The primary control of Nrf2 function lies on its subcellular distribution rather than on the induction of the protein(Reference Gopalakrishnan and Tony Kong11, Reference Chen and Tony Kong17). Nrf2 is sequestered in the cytoplasm as an inactive complex with its cytosolic repressor Kelch-like erythroid cell-derived protein with CNC homology (ECH)-associated protein 1 (Keap-1). Dissociation of Nrf2 from Keap-1 is crucial for its nuclear translocation, followed by binding to the DNA and activation of cytoprotective genes(Reference Hara18). In addition, different signal transduction pathways related to cell survival and proliferation (MAPK, phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT), protein kinase C) might regulate Nrf2(Reference Gopalakrishnan and Tony Kong11, Reference Chen and Tony Kong17). Indeed, Nrf2 phosphorylation by different kinases at multiple sites seems to be an important mechanism in Nrf2-mediated antioxidant response element activation and in regulating the stability of this transcription factor(Reference Nguyen, Sherratt and Huang19, Reference Pi, Bai and Reece20).
Redox-sensitive transcription factor (NF-κB, AP-1 and Nrf2) pathways are known to be important molecular targets in chemoprevention(Reference Shen, Jeong and Hu21). A cross-talk between upstream signalling pathways (MAPK, PI3K and protein kinase C) leading to differential modulation of these transcription factors appears to connect them, although evidence confirming a direct link among the transcription factors Nrf2, NF-κB and AP-1 is lacking. Epicatechin seems not to affect AP-1 activity(Reference Chung, Huang and Meng22), but stimulates Nrf2 nuclear translocation(Reference Bahia, Rattray and Williams23) and inhibits NF-κB activity(Reference Mackenzie and Oteiza24) in astrocytes and lymphoma cells, respectively, similarly to the epicatechin dimer, procyanidin B2(Reference Mackenzie, Adamo and Decker25). On the other hand, this flavanol and its dimer can inhibit NF-κB activation induced by various agents(Reference Kim, Ryu and Kang26, Reference Mackenzie, Carrasquedo and Delfino27). However, comparable studies about the mechanisms underlying the chemopreventive effects of epicatechin alone related to transcription factors are limited. Most of these studies have been carried out after long-term treatments, but potential variations of the observed effects could take place in a time-dependent manner.
The present study analyses the influence of epicatechin, followed over time, on the mechanisms related to the regulation of major transcription factors (NF-κB, AP-1 and Nrf2) in HepG2 cells. Results demonstrate that the survival effect of epicatechin is due to the early-initiated merged induction of critical redox-sensitive transcription factors linked to pro-survival pathways.
Experimental methods
Materials and chemicals
Epicatechin, 4′,6-diamidino-2-phenylindole, diphenyleneiodonium (DPI), wortmannin, 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one (PD98059), bovine serum albumin, gentamicin, penicillin G and streptomycin were purchased from Sigma Chemical (Madrid, Spain). Anti-NF-κB p65 (sc-7151 and sc-372), anti-IKKα (sc-7218 and sc-7607), anti-IκBα (sc-371), anti-phospho-Ser32-IκBα (sc-21869-R), anti c-Jun (sc-1694), anti-Nrf2 (C-20, sc-722), anti-Nrf2 (H-300, sc-13032), anti-poly(ADPribose)polymerase (anti-PARP) (sc-7150) and anti-growth factor receptor-bound protein 2 (sc-255) were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Alexa Fluor 594 goat anti-rabbit IgG (H+L) (A11012) and anti-β-actin (4697) were obtained from Molecular Probes (Invitrogen, Merelbeke, Belgium) and Cell Signalling Technology (Izasa, Madrid, Spain), respectively. Reagents and consensus oligonucleotides for the electrophoretic mobility shift assays were from Promega (Madrid, Spain). Materials and chemicals for electrophoresis were from BioRad (Madrid, Spain). Cell-culture dishes and cell-culture medium were from Falcon (Cajal, Madrid, Spain) and Biowhitaker Europe (Lonza, Madrid, Spain), respectively. Vectashield was obtained from Vector Laboratories, Inc. (Burlingame, CA, USA).
Cell culture, epicatechin treatment and obtaining of cell lysates
Human hepatoma HepG2 cells were grown in Dulbecco's modified Eagle F-12 medium supplemented with 2·5 % fetal bovine serum and antibiotics (50 mg/l; penicillin, streptomycin and gentamicin). Cells were kept at 37°C in a humidified atmosphere with 5 % CO2.
To study the time-course effects of epicatechin, cells were grown in serum-free Dulbecco's modified Eagle F12 medium for 24 h before the assay, because the growth factors contained in the fetal bovine serum might influence the results. Subsequently, cells were treated with 10 μm-epicatechin and harvested at different incubation times (0, 5, 10, 15, 30, 60, 120, 240 and 1080 min).
In the experiments with epicatechin and the ROS scavenger, DPI, cells were pre-incubated with DPI (20 μm) for 30 min before 10 μm-epicatechin treatment during 240 or 1080 min. Similarly, when cells were treated with epicatechin and the inhibitors wortmannin (200 nm) or PD98059 (50 μm), cells were pre-incubated for 2 h with the inhibitor before flavanol (10 μm) treatment for 240 or 1080 min.
To obtain the total cell lysates and detect IκB and phosphorylated IκB, cells were harvested after different incubation times with epicatechin and centrifuged at 300 g, 4°C for 5 min. Cells were lysed in cold buffer composed of 25 mm-HEPES (pH 7·5), 0·3 m-NaCl, 1·5 mm-MgCl2, 0·2 mm-EDTA, 0·5 mm-dithiothreitol, 0·1 % Triton X-100, 200 mm-β-glycerolphosphate, 0·1 mm-Na3VO4, 2 μg/ml leupeptin and 1 mm-phenylmethylsulfonyl fluoride(Reference Fabregat, Herrera and Fernandez28). Lysates were centrifuged at 10 000 g, 4°C for 10 min. The supernatant fractions were collected to determine protein concentration by the Bio-Rad (Madrid, Spain) protein assay kit, and total cell lysates were sampled and stored at − 80°C until use for Western blotting analysis.
To obtain the nuclear and cytosolic cell lysates and detect NF-κB, IKK, c-Jun and Nrf2, cells were incubated with cold lysis buffer A, containing 10 mm-HEPES (pH 7·9), 1·5 mm-MgCl2, 10 mm-KCl, 0·5 mm-dithiothreitol and 0·2 mm-phenylmethylsulfonyl fluoride for 10 min. Next, samples were centrifuged at 10 000 g, 4°C for 10 min and the supernatant fractions (cytosolic cell extracts) were collected to determine protein concentration. Pellets were re-suspended in cold lysis buffer B, composed of 20 mm-HEPES (pH 7·9), 25 % glycerol, 420 mm-NaCl, 1·5 mm-MgCl2, 0·2 mm-EDTA, 0·5 mm dithiothreitol, 2·5 μg/ml leupeptin, 0·2 mm-phenylmethylsulfonyl fluoride and 2·5 μg/ml aprotinin, and kept for 20 min on ice. Samples were centrifuged at 14 000 g, 4°C for 10 min and the supernatant fractions (nuclear cell extracts) were collected to analyse protein concentration. Both cell extracts were stored at − 80°C until use for Western blotting or electrophoretic mobility shift assay.
Protein analysis by Western blotting
Equal amounts of protein (100 μg) were separated by SDS-PAGE. Proteins were transferred to polyvinylidene difluoride filters (Protein Sequencing Membrane; Millipore, Madrid, Spain). Membranes were incubated with the corresponding primary antibody and then with peroxide-conjugated anti-rabbit Ig as the secondary antibody (GE Healthcare, Madrid, Spain). Blots were developed with the ECL Western blotting detection reagents (GE Healthcare, Madrid, Spain). Anti-growth factor receptor-bound protein-2 and anti-poly(ADPribose)polymerase (anti-PARP) antibodies were used as markers for the cytosolic and nuclear extracts, respectively. Equal loading of Western blot was ensured by β-actin and band quantification was carried out with a scanner and the Scion Image software (Scion Corp., Frederick, MD, USA).
Electrophoretic mobility shift assay
Equal amounts of protein (5–10 μg) were incubated for 20 min at room temperature with NF-κB or AP-1-α-32P-labelled consensus oligonucleotides in binding buffer, as previously described(Reference Wen and Locker29). Labelling was performed by using T4 polynucleotide kinase and α-32P-labelled deoxyadenosine triphosphate, being NF-κB and AP-1 consensus oligonucleotides: 5′-AGTTGAGGGGACTTTCCCAGGC-3′ and 5′-CGCTTGATGAGTCAGCCGGAA-3′, respectively. The binding reaction mixture contained 0·5 ng of doubled-stranded oligonucleotide probe, 1 μg of poly(dI-dC) and nuclear extracts in 2 μl incubation buffer (50 mm-2-amino-2-hydroxymethyl-propane-1,3-diol (Tris)–HCl (pH 7·5), 250 mm-NaCl, 5 mm-MgCl2, 2·5 mm-EDTA, 2·5 mm-dithiothreitol and 20 % glycerol). Samples were loaded on a 6 % polyacrylamide gel and were separated via electrophoresis at 150 mV in 0·53 mm-Tris–borate–EDTA running buffer for 2–3 h, at room temperature. Then, the gel was autoradiographed and the complexes quantified by using a scanner and accompanying software.
Immunofluorescence microscopy
Immunofluorescence assays were performed as previously described(Reference Pierreux, Nicolas and Hill30, Reference De Bosscher, Vanden Berghe and Beck31). Briefly, HepG2 cells were seeded (25 000 cells/well) on glass coverslips with Dulbecco's modified Eagle F-12 medium supplemented with fetal bovine serum for 24 h and changed to serum-free medium 24 h before the assay. After incubation with epicatechin for the indicated times, cells were washed with PBS at room temperature and then fixed with 3·7 % paraformaldehyde for 10 min at room temperature. Cells were rinsed with PBS, permeabilised with ice-cold acetone and subsequently blocked with 1 % bovine serum albumin. Cells were incubated with the corresponding primary antibody, as indicated in the legends of Figs. 2 and 6, and then incubated with the anti-rabbit Alexa Fluor-594 conjugated secondary antibody. Nuclei were visualised by using 6-diamidino-2-phenylindole staining. The coverslips were mounted in Vectashield and images were taken with a Zeiss Axiovert 200M immunofluorescence microscope (Carl Zeiss Microimaging GmbH, Munich, Germany) at 63 × magnification. AxioVisionRel 4.6 software was used for the analysis of the images obtained.
Statistics
Before statistical analysis, data were tested for homogeneity of variances by the test of Levene; for multiple comparisons, one-way ANOVA was followed by the Bonferroni test when variances were homogeneous or by the Tamhane test when variances were not homogeneous. P < 0·05 was considered significant. SPSS (version 15.0; SPSS, Inc., Chicago, IL, USA) was used.
Results
Time-course effects on NF-κB pathway
NF-κB regulation
To study the time-course effect of epicatechin on NF-κB in HepG2 cells, cytosolic and nuclear NF-κB(p65) levels were analysed. As shown in Fig. 1(A) and (B), epicatechin increased the nuclear translocation of NF-κB after 5 min of treatment and remained enhanced up to 240 min, observed by the remarkable augmentation in the relative amount of nuclear v. cytosolic NF-κB levels. The nuclear:cytosolic NF-κB ratio returned to control levels at 1080 min (Fig. 1(A) and (B)).
Time-dependent effect of epicatechin on modulation of NF-κB(p65) cytosolic (cyt) and nuclear (nuc) levels. (A) Bands of representative experiments. Anti-growth factor receptor-bound protein-2 (GRB2) and anti-poly(ADPribose)polymerase (anti-PARP) antibodies were used as markers for the cyt and nuc extracts, respectively. (B) Nuc:cyt NF-κB ratio of bands determined by densitometric quantification. Values are means (n 6), with standard deviations represented by vertical bars. a,b,c Mean values with unlike letters were significantly different (P < 0·05).
Phosphorylation and degradation of inhibitor of κBα protein
To further investigate the regulation of upstream components of the NF-κB signalling pathway, IκBα modulation was studied. Epicatechin induced the phosphorylation of IκBα after a short incubation time (5 min), which was maintained up to 10 min and then slowly decreasing to control levels (15–1080 min) (Fig. 2(A) and (B)).
Time-dependent effect of epicatechin on phosphorylated inhibitor of κB protein (p-IκB)-α (Ser32) and total IκBα levels. (A) Representative blots. Normalisation of Western blots, either p-IκBα or total IκBα levels, was ensured by β-actin. (B) Percentage values of p-IκBα levels relative to the control condition, determined by densitometric quantification. Values are means (n 6), with standard deviations represented by vertical bars. a,b Mean values with unlike letters were significantly different (P < 0·05). (C) Percentage values of total IκBα levels relative to the control, determined by densitometric quantification. Values are means (n 6), with standard deviations represented by vertical bars. a–e Mean values with unlike letters were significantly different (P < 0·05). (D) Immunofluorescence images of time-dependent status and cellular localisation of IκBα (red signal). 6-Diamidino-2-phenylindole (DAPI) staining was used to visualise nuclei (blue signal). These results are representative of two independent experiments.
IκBα degradation was observed after 5 min of treatment with epicatechin and remained diminished until 240 min (Fig. 2(A) and (C)). Additionally, fluorescence microscopy showed the cytosolic localisation of IκBα as well as its degradation (Fig. 2(D)). In this analysis, IκBα levels were clearly decreased up to 240 min, returning to control levels at 1080 min of incubation (Fig. 2(D)).
Regulation of the IκB kinase complex
IKK is a complex composed of two catalytic subunits (IKKα and IKKβ) and a regulatory subunit (NF-κB essential modifier (NEMO)/IKKγ), which are upstream kinases of IκBα(Reference Gloire, Dejardin and Piette32). Recent studies have provided evidence that IKK subunits also translocate into the nucleus to regulate NF-κB-dependent and -independent gene expression(Reference Gloire, Dejardin and Piette32). To gain more insight into the NF-κB pathway regulation, cytosolic and nuclear levels of both catalytic subunits of IKK (IKKα/β) were analysed. Western blot analysis demonstrated that cytosolic IKKα levels were increased after 5 min of treatment, and remained enhanced up to 2 h, showing lower levels than controls after 18 h of incubation (Fig. 3(A) and (B)). An opposite effect was observed on the cytosolic IKKβ levels, which clearly decreased after 5 min up to 240 min, returning to control values after 1080 min of treatment (Fig. 3(A) and (B)).
Time-course effect of epicatechin on cytosolic (cyt) and nuclear (nuc) IκB kinase (IKK)-α and IKKβ levels. (A) Representative blots. Anti-growth factor receptor-bound protein-2 (anti-GRB2) and anti-poly(ADPribose)polymerase (anti-PARP) antibodies were used as markers for the cyt and nuc extracts, respectively. (B) Percentage values of cyt levels of IKKα (■) and IKKβ (□) relative to the control conditions, determined by densitometric quantification. Values are means (n 6), with standard deviations represented by vertical bars. a,b,c Mean values (for IKKα or IKKβ) with unlike letters were significantly different (P < 0·05). (C) Percentage values of nuc levels of IKKα (■) and IKKβ (□) relative to the control conditions, determined by densitometric quantification. Values are means (n 6), with standard deviations represented by vertical bars. a,b,c Mean values (for IKKα or IKKβ) with unlike letters were significantly different (P < 0·05).
In the nucleus, after a prior enhancement of the IKKα levels at 5–10 min of incubation, epicatechin induced a decrease at 15 min, which was maintained up to 1080 min (Fig. 3(A) and (C)). Parallel to this, epicatechin evoked an increase in the nuclear IKKβ levels, which remained enhanced up to 60 min to return to control levels from 120 min of treatment onwards (Fig. 3(A) and (C)).
Time-course effects on NF-κB activity
To further investigate the time-course effect of epicatechin on the NF-κB pathway, NF-κB DNA-binding activity was studied. Epicatechin induced an early increase of NF-κB activity (5 min), which remained enhanced up to 240 min and reached control values at the longest incubation time (1080 min) (Fig. 4).
Time-course effect of epicatechin on NF-κB activity. (A) Representative autoradiography of NF-κB electrophoretic mobility shift assay (EMSA). ( ← ), Positions of specific NF-κB–DNA complexes. Negative controls ( − ) without nuclear extract and positive controls (+) with a pure HeLa nuclear extract were included in each experiment. To determine the specificity of the NF-κB–DNA complexes, a nuclear fraction was incubated in the presence of 100-fold excess of unlabelled oligonucleotide containing the consensus sequence for either an unspecific competitor (activator protein-1; AP-1) or specific competitor (NF-κB) before the binding assay. (B) NF-κB activity as a percentage relative to the control condition, determined by densitometric quantification. Values are means (n 6), with standard deviations represented by vertical bars. a,b,c Mean values with unlike letters were significantly different (P < 0·05).
Time-course modulation of activator protein-1 and c-Jun
To study the time-dependent epicatechin effect on AP-1 DNA-binding activity, as well as on cytosolic and nuclear c-Jun levels, both parameters were assayed for the indicatedtimes.
Activator protein-1 DNA-binding activity
Epicatechin induced an early increase of the AP-1 DNA-binding activity (5 min), which remained higher than controls up to 1080 min (Fig. 5).
Time-course-dependent effect of epicatechin on activator protein-1 (AP-1) activity. (A) Representative autoradiography of AP-1 electrophoretic mobility shift assay (EMSA). ( ← ), Positions of specific AP-1–DNA complexes. Negative controls ( − ) without nuclear extract and positive controls (+) with a pure HeLa nuclear extract were included in each experiment. To determine the specificity of the AP-1–DNA complexes, a nuclear fraction was incubated in the presence of 100-fold excess of unlabelled oligonucleotide containing the consensus sequence for either an unspecific competitor (activator protein-2; AP-2) or specific competitor (AP-1) before the binding assay. (B) AP-1 activity as a percentage relative to the control condition, determined by densitometric quantification. Values are means (n 7), with standard deviations represented by vertical bars. a,b,c Mean values with unlike letters were significantly different (P < 0·05).
Subcellular levels and localisation of c-Jun
As shown in Fig. 6, c-Jun protein was mainly located in the nucleus of HepG2 cells. In agreement with the previous results of AP-1 activity, epicatechin induced an early enhancement of the nuclear c-Jun protein levels (5 min), which was sustained up to the longest incubation time (1080 min) (Fig. 6(A)). The nuclear localisation of the protein was also shown by the immunofluorescence analysis (Fig. 6(B)).
Time-dependent effect of epicatechin on cytosolic (cyt) and nuclear (nuc) levels and subcellular localisation of c-Jun. (A) Representative bands (n 3). Anti-growth factor receptor-bound protein-2 (anti-GRB2) and anti-poly(ADPribose)polymerase (anti-PARP) antibodies were used as markers for the cyt and nuc extracts, respectively. (B) Immunofluorescence images of the subcellular localisation of c-Jun (red signal). 6-Diamidino-2-phenylindole (DAPI) staining was used to visualise nuclei (blue signal). These results are representative of two independent experiments.
Time-course nuclear transcription factor erythroid 2p45-related factor-2 modulation
To assess the implication of Nrf2 on epicatechin effects, time-course studies on the nuclear and cytosolic levels of this transcription factor were performed. No phosphorylated Nrf2 (100 kDa) was detected in the cytosolic fractions of HepG2 cells. Epicatechin concurrently increased nuclear translocation of Nrf2 (57 kDa) and nuclear content of phosphorylated Nrf2 (100 kDa) after 15 min of treatment (Fig. 7(A)–(C)). This effect remained for up to 240 min as can be deduced from the increment in the nuclear content and nuclear:cytosolic ratio of Nrf2 (Fig. 7(A)–(C)). Control levels were attained at 1080 min of incubation.
Time-course effect of epicatechin on cytosolic (cyt) and nuclear (nuc) nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) levels (100 and 57 kDa). (A) Bands of representative experiments. Anti-growth factor receptor-bound protein-2 (anti-GRB2) and anti-poly(ADPribose)polymerase (anti-PARP) antibodies were used as markers for the cyt and nuc extracts, respectively. (B) Percentage values of nuc levels of phosphorylated Nrf2 (100 kDa) relative to the control condition, determined by densitometric quantification. Values are means (n 6), with standard deviations represented by vertical bars. a,b Mean values with unlike letters were significantly different (P < 0·05). (C) Nuc:cyt Nrf2 (57 kDa) ratio of bands, determined by densitometric quantification. Values are means (n 6), with standard deviations represented by vertical bars. a,b Mean values with unlike letters were significantly different (P < 0·05).
Epicatechin-induced nuclear transcription factor erythroid 2p45-related factor-2 and NF-κB expressions are mediated by reactive oxygen species, phosphatidylinositol-3-kinase and extracellular regulated kinase 1/2
Nrf2 and NF-κB have also been related to ROS and survival and proliferation pathways(Reference Gopalakrishnan and Tony Kong11, Reference Naugler and Karin13, Reference Chen and Tony Kong17). Since an epicatechin-dependent ROS attenuation and AKT and ERK activation have been reported(Reference Granado-Serrano, Martín and Izquierdo-Pulido4, Reference Granado-Serrano, Martín and Goya5), the possible implication of these factors on the regulation of NF-κB and Nrf2 expressions was analysed after 4 and 18 h of incubation. As shown in Fig. 8(A)–(D), DPI prevented the phosphorylation and nuclear translocation of Nrf2 induced by the flavanol at 4 h, which were also diminished below control levels at the longest incubation time (18 h), as shown by the remarkable decrease in the nuclear phosphorylated content and nuclear:cytosolic ratio. Both the nuclear:cytosolic ratio and nuclear phosphorylated Nrf2 levels (100 and 57 kDa, respectively) remained unaltered after treating control cells with DPI at 4 and 18 h. On the other hand, DPI treatment also decreased the epicatechin-induced NF-κB levels at both tested times (Fig. 8(E) and (F)), resulting in the inhibition of NF-κB(p65) nuclear translocation. DPI alone provoked an inhibition of the NF-κB translocation at 18 h, although levels similar to controls were observed after 4 h of incubation.
Effects of epicatechin (EC) and diphenyleneiodonium (DPI) on cytosolic (cyt) and nuclear (nuc) nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) (100 and 57 kDa) and NF-κB levels. HepG2 cells were incubated with or without 10 μm-EC for 240 or 1080 min in the presence or absence of 20 μm-DPI. (A, C, E) Bands of representative experiments. Anti-growth factor receptor-bound protein-2 (anti-GRB2) and anti-poly(ADPribose)polymerase (anti-PARP) antibodies, used as markers for the cyt and nuc extracts, respectively, were not included in the plots due to the complexity of the figures. (B) Percentage of 100 kDa nuc Nrf2 relative to the control (C) condition after 240 (■) and 1080 (□) min of incubation in the presence or absence of DPI, determined by densitometric quantification. Values are means (n 5–6), with standard deviations represented by vertical bars. a,b,c Mean values (for the 240 or 1080 min condition) with unlike letters were significantly different (P < 0·05). (D) Nuc:cyt Nrf2 (57 kDa) ratio after 240 (■) and 1080 (□) min of incubation in the presence or absence of DPI, determined by densitometric quantification. Values are means (n 5–6), with standard deviations represented by vertical bars. a,b,c Mean values (for the 240 or 1080 min condition) with unlike letters were significantly different (P < 0·05). (F) Nuc:cyt NF-κB ratio after 240 (■) and 1080 (□) min of incubation in the presence or absence of DPI, determined by densitometric quantification. Values are means (n 5–6), with standard deviations represented by vertical bars. a,b,c Mean values (for the 240 or 1080 min condition) with unlike letters were significantly different (P < 0·05).
Treatment of HepG2 cells with wortmannin, an inhibitor of AKT, followed by addition of epicatechin (10 μm), diminished the Nrf2-induced activation (57 and 100 kDa Nrf2 levels), returning to control levels at 4 h. After 18 h of incubation, the nuclear phosphorylated content and nuclear:cytosolic ratio of Nrf2 (100 and 57 kDa) decreased below control levels (Fig. 9(A)–(D)). NF-κB nuclear translocation was unaltered after treating the cells with epicatechin and wortmannin at both times (4 and 18 h) (Fig. 9(E) and (F)). In addition, wortmannin alone inhibited phosphorylation and nuclear translocation of Nrf2 and did not alter the nuclear:cytosolic ratio of NF-κB at both incubation times (Fig. 9).
Effects of epicatechin (EC) and wortmannin (W) on cytosolic (cyt) and nuclear (nuc) nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) (100 and 57 kDa) and NF-κB levels. HepG2 cells were incubated with or without 10 μm-EC for 240 or 1080 min in the presence or absence of 200 nm-W. (A, C, E) Bands of representative experiments. Anti-growth factor receptor-bound protein-2 (anti-GRB2) and anti-poly(ADPribose)polymerase (anti-PARP) antibodies, used as markers for the cyt and nuc extracts, respectively, were not included in the plots due to the complexity of the figures. (B) Percentage of 100 kDa nuc Nrf2 relative to the control (C) condition after 240 (■) and 1080 (□) min of incubation in the presence or absence of W, determined by densitometric quantification. Values are means (n 5–6), with standard deviations represented by vertical bars. a,b Mean values (for the 240 or 1080 min condition) with unlike letters were significantly different (P < 0·05). (D) Nuc:cyt Nrf2 (57 kDa) ratio after 240 (■) and 1080 (□) min of incubation in the presence or absence of W, determined by densitometric quantification. Values are means (n 5–6), with standard deviations represented by vertical bars. a,b Mean values (for the 240 or 1080 min condition) with unlike letters were significantly different (P < 0·05). (F) Nuc:cyt NF-κB ratio after 240 (■) and 1080 (□) min of incubation in the presence or absence of W, determined by densitometric quantification. Values are means (n 5–6), with standard deviations represented by vertical bars. a,b Mean values (for the 240 or 1080 min condition) with unlike letters were significantly different (P < 0·05).
Inhibition of epicatechin-induced ERK activation by the ERK selective inhibitor PD98059 after 240 min of incubation led to nuclear phosphorylated levels and a nuclear:cytosolic ratio of Nrf2 (100 and 57 kDa) comparable with those of controls at 4 h of treatment (Fig. 10(A)–(D)). Similarly, a decrease in Nrf2 phosphorylation and nuclear translocation was observed at 18 h in epicatechin+PD98059-treated cells (Fig. 10(A)–(D)). In addition, Nrf2 phosphorylation and translocation were inhibited by PD98059 incubation at 1080 min in control cells (Fig. 10(A)–(D)). Selective blockage of ERK by PD98059 resulted in the inhibition of NF-κB translocation after 4 and 18 h of incubation with epicatechin and PD98059 (Fig. 10(E) and (F)). Moreover, PD98059 alone did not alter the subcellular localisation of NF-κB after 4 and 18 h of incubation (Fig. 10(E) and (F)).
Effects of epicatechin (EC) and 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one (PD98059; PD) on cytosolic (cyt) and nuclear (nuc) nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) (100 and 57 kDa) and NF-κB levels. HepG2 cells were incubated with or without 10 μm-EC for 240 or 1080 min in the presence or absence 50 μm-PD. (A, C, E) Representative blots. Anti-growth factor receptor-bound protein-2 (anti-GRB2) and anti-poly(ADPribose)polymerase (anti-PARP) antibodies, used as markers for the cyt and nuc extracts, respectively, were not included in the plots due to the complexity of the figures. (B) Percentage of 100 kDa nuc Nrf2 relative to the control (C) condition after 240 (■) and 1080 (□) min of incubation in the presence or absence of PD, determined by densitometric quantification. Values are means (n 5–6), with standard deviations represented by vertical bars. a,b Mean values (for the 240 or 1080 min condition) with unlike letters were significantly different (P < 0·05). (D) Nuc:cyt Nrf2 (57 kDa) ratio after 240 (■) and 1080 (□) min of incubation in the presence or absence of PD, determined by densitometric quantification. Values are means (n 5–6), with standard deviations represented by vertical bars. a,b Mean values (for the 240 or 1080 min condition) with unlike letters were significantly different (P < 0·05). (F) Nuc:cyt NF-κB ratio after 240 (■) and 1080 (□) min of incubation in the presence or absence of PD, determined by densitometric quantification. Values are means (n 5–6), with standard deviations represented by vertical bars. a,b,c Mean values (for the 240 or 1080 min condition) with unlike letters were significantly different (P < 0·05).
Discussion
Polyphenols have been shown to possess anti-inflammatory, anti-thrombogenic, antioxidant and anticarcinogenic activities(Reference Ramos1, Reference Noé, Peñuelas and Lamuela-Raventós9, Reference Nijveldt, van Nood and van Hoorn33). Recently, much interest has been focused on analysing these biological properties, as polyphenolic compounds seem to act on cellular oxidative stress, antioxidant metabolism, cell-cycle regulation, induction and/or suppression of apoptosis and cell signalling(Reference Noé, Peñuelas and Lamuela-Raventós9, Reference Williams, Spencer and Rice-Evans10). Since NF-κB, AP-1 and Nrf2 play a central role in the cell antioxidant defence, survival and proliferation, these transcription factors were investigated as epicatechin targets. We have reported that epicatechin (10 μm) induces an enhancement of the intrinsic cellular tolerance against oxidative insults, a transient attenuation of intracellular ROS levels and a sustained activation of major survival and proliferation signalling proteins (AKT, ERK, etc), in concert with an early inactivation of key death-related signals(Reference Granado-Serrano, Martín and Izquierdo-Pulido4, Reference Granado-Serrano, Martín and Goya5). In the present study, we show that epicatechin transiently activates the NF-κB cascade and Nrf2 signalling by stimulating PI3K/AKT and ERK pathways and induces a sustained enhancement of AP-1-binding-activity by up-regulating the nuclear levels of c-Jun.
It is noteworthy to mention that the concentration of 10 μm-epicatechin used in the study is not far from realistic. In human subjects, levels of 0·2–0·4 μm-epicatechin have been observed after ingestion of 50 g(Reference Wang, Schramm and Holt34) and 80 g(Reference Rein, Lotito and Holt35) chocolate and 426 ml green tea containing 76·5 mg epicatechin(Reference Henning, Niu and Lee36). Moreover, rats fed with epicatechin showed plasma concentrations of epicatechin and epicatechin metabolites of about 35 μm at 1 h after oral administration of 172 μmol epicatechin/kg body weight(Reference Baba, Osakabe and Natsume37). However, at present the potential contribution of the epicatechin metabolites to the biological activity is unclear and it should not be underestimated(Reference Basu-Modak, Gordon and Dobson38, Reference Spencer, Schroeter and Kuhnle39); its evaluation will require further studies. In this regard, a more accurate approach recently used is the incubation of cultured cells with plasma obtained from volunteers consuming the molecule or food of interest(Reference Canali, Ambra and Stelitano40).
Activation of the NF-κB signalling pathway by epicatechin appeared to be mediated by an early increase of the NF-κB(p65) nuclear translocation, which was accompanied by transiently increased phosphorylated IκBα levels and subsequent proteolytic degradation of IκB, consistent with the increased NF-κB-binding activity. Later, phosphorylation of IκBα was returned to control levels by the epicatechin treatment, suggesting that the stimulating effects of this polyphenol occur upstream of IκBα(Reference Naugler and Karin13). In this regard, it has been reported that IKKβ plays a main role in NF-κB activation and that its absence causes death due to extensive liver damage from apoptosis(Reference Gloire, Dejardin and Piette32), while IKKα is crucial for a correct development as well as for cell proliferation and differentiation(Reference Gloire, Dejardin and Piette32). Moreover, recent studies have demonstrated that IKK subunits can translocate into the nucleus where IKKα, among other activities, mediates NF-κB transcription and cell proliferation(Reference Gloire, Dejardin and Piette32, Reference Luo, Tan and Ricono41), although the nuclear accumulation of this protein has been related to the promotion of apoptosis through a novel molecular mechanism(Reference Furuya, Ozaki and Hanamoto42). Nuclear IKKβ would recruit to NF-κB-dependent promoters, such as IκB(Reference Gloire, Dejardin and Piette32, Reference Schwabe and Sakurai43). Therefore, early epicatechin-induced IKKα and IKKβ nuclear translocation could be correlated to the enhanced NF-κB-binding activity by IKKα and to IκB phosphorylation by IKKβ. In addition, several studies have also reported that IKKβ phosphorylates multiple NF-κB(p65) sites, suggesting that this catalytic subunit is not only involved in the pathway leading to IκB degradation, but also in the pathway leading to NF-κB phosphorylation and transactivation(Reference Schwabe and Sakurai43, Reference Sakurai, Chiba and Miyoshi44). All this is in agreement with previously reported stimulatory effects of IKK induced by other flavonoids in Chang liver cells(Reference Garcia-Mediavilla, Crespo and Collado45). However, in different cell types, under NF-κB-stimulated conditions other authors have reported inhibitory effects evoked by epicatechin, such as decreased NF-κB(p65) levels and IKK phosphorylation, inhibition of both NF-κB nuclear translocation and NF-κB-binding activity, as well as inhibition of the induction of IκB phosphorylation and degradation(Reference Mackenzie and Oteiza24, Reference Kim, Ryu and Kang26, Reference Mackenzie, Carrasquedo and Delfino27, Reference Jeong, Kim and Hu46).
Numerous reports have demonstrated that AP-1, in addition to its pro-apoptotic function, is also critically involved in cell survival, proliferation, transformation and differentiation(Reference Hess, Angel and Schorpp-Kistner15). An extended explanation for these functions is that a robust and persistent activation of AP-1 in DNA-damaged cells may trigger apoptosis, but the activation of AP-1 in capable proliferative cells promotes proliferation and survival(Reference Czaja14, Reference Hess, Angel and Schorpp-Kistner15). In this regard, recent studies have demonstrated that the activation of the AP-1 signalling pathway controls cell proliferation through cell-cycle regulation in hepatocytes and other cell types(Reference Hess, Angel and Schorpp-Kistner15). Opposite to the activation of AP-1 described in the present paper, several studies have reported that epicatechin alone is unable to modify AP-1 activity even in the presence of AP-1 stimulators(Reference Chung, Huang and Meng22, Reference Jeong, Kim and Hu47), although at higher concentrations (100 μm) epicatechin induces an inhibitory effect on AP-1 activity together with a slightly decreased cell viability(Reference Chung, Huang and Meng22). The divergence for AP-1 activity modulation could be related to the specific modulation of transcription factors for the different cell types(Reference Kim, Kim and Kwon48, Reference Lim, Park and Choi49) and to the different concentrations of the flavanol used.
Expression of AP-1 genes is regulated by the phosphorylation and the expression of individual AP-1 components (Jun and Fos). Jun expression is required for fetal hepatocyte survival, whereas in differentiated hepatocytes it is essential for cell-cycle progression(Reference Hess, Angel and Schorpp-Kistner15). Moreover, Jun and NF-κB can collaborate to promote cell survival because of the ability of the c-jun amino-terminal kinase signalling pathway to induce survival or apoptosis depending on the cellular context(Reference Czaja14, Reference Hess, Angel and Schorpp-Kistner15). Accordingly, the increased AP-1 activity and nuclear c-Jun levels induced by epicatechin have been shown to be coordinated with the enhanced nuclear NF-κB levels, as well as with the activation of different key survival and proliferation signals, in agreement with previous results(Reference Granado-Serrano, Martín and Izquierdo-Pulido4, Reference Granado-Serrano, Martín and Goya5). However, other authors have reported that epicatechin treatment of a human colon cell line did not modify c-Jun levels, in accordance with an AP-1 activity similar to controls(Reference Jeong, Kim and Hu47).
Nrf2 is closely involved in the modulation of the antioxidant defence system, as well as in cell survival and proliferation(Reference Gopalakrishnan and Tony Kong11, Reference Marhenke, Lamle and Buitrago-Molina50). In line with this, it has been demonstrated that polyphenols alone could activate Nrf2(Reference Bahia, Rattray and Williams23, Reference Lim, Park and Choi49), which is in agreement with the present study. Phosphorylated Nrf2 (100 kDa) was not detected in the cytosolic fractions of HepG2 cells, as previously shown(Reference Nguyen, Sherratt and Huang19). Nrf2 phosphorylation has been described as a critical event for the nuclear translocation of this transcription factor, as well as for its transcriptional activity(Reference Nguyen, Sherratt and Huang19, Reference Pi, Bai and Reece20); this last feature could be related to the nuclear phosphorylated Nrf2 levels described in the present study. In this context, it is interesting to note that the activation of Nrf2 and NF-κB could be modulated by ROS, MAPK (ERK), protein kinase C and PI3K(Reference Gopalakrishnan and Tony Kong11, Reference Chen and Tony Kong17, Reference Nguyen, Sherratt and Huang19, Reference Pi, Bai and Reece20).
ROS seem to play an important role in Nrf2 and NF-κB activation, since low ROS levels induce Nrf2, whereas an intermediate amount of ROS trigger the activation of NF-κB and a high level of oxidative stress could result in apoptosis or necrosis(Reference Gloire, Legrand-Poels and Piette51). Previously, we have shown that epicatechin treatment (10 μm) causes a transient decrease of ROS (starting at 30 min) in HepG2 cells(Reference Granado-Serrano, Martín and Goya5). In this regard, it has been reported that attenuation of ROS release by natural antioxidant compounds is accompanied by increased Nrf2 accumulation in the nucleus and increased transcriptional activity of Nrf2(Reference Hwang and Jeong52); in addition, a transient modification of ROS production could result in the modulation of genes related to oxidative stress defence, as well as survival and proliferation signals in HepG2 cells(Reference Gong, Hu and Cederbaum53) and a blocked ROS production in HepG2 cells inhibited Nrf2-induced expression and nuclear translocation(Reference Gong, Hu and Cederbaum53). Thus, these results suggest the importance of intracellular ROS levels for epicatechin-induced Nrf2 and NF-κB activation in HepG2 cells.
Activation of Nrf2 and NF-κB involves regulation of protein kinases(Reference Chen and Tony Kong17, Reference Bahia, Rattray and Williams23, Reference Sethi, Sung and Aggarwal54), which may induce their nuclear translocation, as well as Nrf2 phosphorylation(Reference Pi, Bai and Reece20). We have previously shown that epicatechin treatment (10 μm) induces cellular survival by activating key kinases in HepG2 cells(Reference Granado-Serrano, Martín and Goya5). In this regard, specific protein kinase inhibitors of PI3K and ERK repressed Nrf2 phosphorylation and nuclear translocation of Nrf2 and NF-κB in HepG2 untreated cells, as previously reported in different cell types(Reference Nguyen, Sherratt and Huang19, Reference Bahia, Rattray and Williams23, Reference Sethi, Sung and Aggarwal54–Reference Lee, Hanson and Chu56). These findings point out that PI3K/AKT and/or ERK signalling pathways are required for Nrf2 and NF-κB activation in HepG2 cells. The present results also suggest that the ERK pathway plays a role in the epicatechin-induced activation of phosphorylation and nuclear translocation of Nrf2 and NF-κB and that the PI3K/AKT pathway does not significant affect NF-κB. Reduction of NF-κB activation by the inhibition of the ERK pathway has also been reported on the NF-κB pathway stimulated with TNF(Reference Williams, Lali and Willetts57). Additionally, it should be mentioned that increased PI3K/AKT activity has been linked to the activation of Nrf2(Reference Bahia, Rattray and Williams23, Reference Hwang and Jeong52, Reference Lee, Hanson and Chu56, Reference Beyer, Xu and Teupser58) and to an enhanced transcriptional activity of NF-κB in different cell types(Reference Sethi, Sung and Aggarwal54, Reference Kane, Shapiro and Stokoe55), although in our model AKT seems not to be connected to NF-κB activation. However, an unchanged AKT expression along with inhibited NF-κB activation have been reported previously in cells exposed to ionising stimuli(Reference Kim, Kim and Kwon48). Thus, modulation of Nrf2 and NF-κB nuclear translocation by PI3K/AKT and ERK reinforces the idea that both transcription factors exert critical and supporting functions in the regulation of hepatocyte survival and proliferation pathways. Importantly, it has been suggested that the role of each pathway in the regulation of these transcription factors (Nrf2 and NF-κB) and their molecular targets might be specific to the nature of the stimuli and cell type(Reference Kim, Kim and Kwon48, Reference Lim, Park and Choi49).
In summary, new insights are provided into the relative contribution of epicatechin on major transcription factors associated with cell survival and proliferation pathways in HepG2 cells. Epicatechin early activates the NF-κB pathway by modulating NF-κB-related proteins, as well as the AP-1 route via nuclear accumulation of c-Jun. The induction of the redox-sensitive transcription factor NF-κB was connected to ERK, which are involved in the control of hepatic cell survival and proliferation. Similarly, Nrf2 was activated at an early time by the flavonoid and modulated by PI3K/AKT and ERK pathways. All these features provide evidence for a role of epicatechin in the promotion of cell protection and survival pathways.
Acknowledgements
The present study was supported by the grants AGL2004-302, AGL2007-64042 and CSD2007-00063 from the Spanish Ministry of Science and Innovation (CICYT) and 200870I198 (CSIC). A. B. G.-S. is a predoctoral fellow of the Spanish Ministry of Science and Education. The authors thank Dr de Bosscher and Ine Vanherpe for their expert assistance with the immunofluorescence technique.
A. B. G.-S. participated in culturing HepG2 cells, performing Western blots, electrophoretic mobility shift assays and immunofluorescence assays, and in drafting and revising the manuscript. M. A. M. participated in culturing HepG2 cells, electrophoretic mobility shift assays and in revising the manuscript. G. H. participated in the supervision of the immunofluorescence analysis, and in critical review of and revision of the manuscript. L. G. and L. B. participated in the study design and critical review of and revision of the manuscript. S. R. participated in Western blot and electrophoretic mobility shift assays, study design and coordination, supervision of experimental conduct and analysis, drafting and revision of the manuscript, and approved the final version.
The authors declare that there are no conflicts of interest.
